Ion Biotechnology®, a registered trademark of Grupo Ion Biotech, S.A.P.I. de C.V., the parent company of Ion Biotechnology México, S.A. de C.V. has an assigned nonprovisional patent pending status in Mexico with an exclusive agreement to develop Pharmaceutical, OTC, and Nutritional products using the proprietary IBAL Formulations. Ion Biotechnology México, S.A. de C.V., has the right to contract, manufacture and sublicense all commercial distribution in Mexico, Central, and South America. In addition, the agreement provides for additional patentability of all current and future developments in these territories.
The IBAL technology is based on science, chemistry, and biology. Ion Biotechnology® harnesses cellular and biomolecular processes to develop products that help improve our health and lives. We are continually building a cooperative team of researchers, molecular engineers, biomedical engineers, medical doctors, and pharmaceutical manufacturers to create novel medicines that benefit individuals and society while bringing new scientific understanding to diseases.
